Related references
Note: Only part of the references are listed.Wnt/β-catenin Signaling in Embryonic Stem Cell Self-renewal and Somatic Cell Reprogramming
Toshio Miki et al.
STEM CELL REVIEWS AND REPORTS (2011)
myc maintains embryonic stem cell pluripotency and self-renewal
Natalia V. Varlakhanova et al.
DIFFERENTIATION (2010)
Role of Lef1 in sustaining self-renewal in mouse embryonic stem cells
Chen Huang et al.
JOURNAL OF GENETICS AND GENOMICS (2010)
Inhibition of proliferation and differentiation and promotion of apoptosis by cyclin L2 in mouse embryonic carcinoma P19 cells
Lili Zhuo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Testis cancer: A 20-year epidemiological review of the experience at a regional military medical facility
Daniel E. Cooper et al.
JOURNAL OF UROLOGY (2008)
The soluble Wnt receptor Frizzled8CRD-hFc inhibits the growth of teratocarcinomas in vivo
Venita I. DeAlmeida et al.
CANCER RESEARCH (2007)
Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch
Sylvie Giuriato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
WNT/β-catenin pathway up-regulates Stat3 and converges on LIF to prevent differentiation of mouse embryonic stem cells
J Hao et al.
DEVELOPMENTAL BIOLOGY (2006)
Defining the role of Wnt/β-catenin signaling in the survival, proliferation, and self-renewal of human embryonic stem cells
G Dravid et al.
STEM CELLS (2005)
Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues
K Hochedlinger et al.
CELL (2005)
Wnt signalling in stem cells and cancer
T Reya et al.
NATURE (2005)
LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism
P Cartwright et al.
DEVELOPMENT (2005)
Gene expression profiling of mouse teratocarcinomas uncovers epigenetic changes associated with the transformation of mouse embryonic stem cells
AE Bonner et al.
NEOPLASIA (2004)
Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor
N Sato et al.
NATURE MEDICINE (2004)
MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer
CM Shachaf et al.
NATURE (2004)
The Wnt signaling pathway in development and disease
CY Logan et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY (2004)
Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors
JM Sperger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
GSK-3β phosphorylation and alteration of β-catenin in hepatocellular carcinoma
KC Ban et al.
CANCER LETTERS (2003)
The Hedgehog and Wnt signaling pathways in cancer
J Taipale et al.
NATURE (2001)
Wnt/β-catenin signaling
T Akiyama
CYTOKINE & GROWTH FACTOR REVIEWS (2000)
Share Paper
